Beyond Air (XAIR) Cash from Investing Activities (2016 - 2026)
Beyond Air (XAIR) posted Cash from Investing Activities of -$447000.0 for Q1 2026, up 88.94% sequentially from -$4.0 million in Q4 2025, and down 117.32% YoY from $2.6 million in Q1 2025.
Beyond Air (XAIR) Cash from Investing Activities (2016 - 2026) Analysis & Trends
Beyond Air has reported Cash from Investing Activities for 11 years, with the latest figure at -$447000.0 in Q1 2026.
- Quarterly Cash from Investing Activities fell 117.32% year-over-year to -$447000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.4 million (down 144.71% YoY) and the FY2026 annual result came in at -$3.7 million, down 124.65% from the prior year.
- Cash from Investing Activities grew to -$447000.0 in Q1 2026 per XAIR's latest filing, from -$4.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $8.9 million in Q3 2024 and troughed at -$33.6 million in Q3 2022.
- A 5-year average of -$1.7 million and a median of -$264000.0 in 2022 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities plunged 4948.27% in 2022, then surged 2713.57% in 2023.
- Over 5 years, Cash from Investing Activities stood at $4.4 million in 2022, then plunged by 80.56% to $853000.0 in 2023, then sank by 913.25% to -$6.9 million in 2024, then jumped by 41.72% to -$4.0 million in 2025, then jumped by 88.94% to -$447000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$447000.0, -$4.0 million, and $486000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Beyond Air | 3.72 Mn | -7.19 Mn | 225,000.00 | 461,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 461,000.00 |
| Jun 30, 2026 | 461,000.00 |
| Mar 31, 2026 | -447,000.00 |
| Mar 31, 2026 | -447,000.00 |
| Dec 31, 2025 | -4.04 Mn |
| Dec 31, 2025 | -4.04 Mn |
| Sep 30, 2025 | 486,000.00 |
| Sep 30, 2025 | 486,000.00 |
| Jun 30, 2025 | 576,000.00 |
| Jun 30, 2025 | 576,000.00 |
| Mar 31, 2025 | 2.58 Mn |
| Mar 31, 2025 | 2.58 Mn |
| Dec 31, 2024 | -6.94 Mn |
| Dec 31, 2024 | -6.94 Mn |
| Sep 30, 2024 | 8.91 Mn |
| Sep 30, 2024 | 8.91 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Mar 31, 2024 | -1.67 Mn |
| Mar 31, 2024 | -1.67 Mn |